Skip to main content
Fig. 4 | Breast Cancer Research

Fig. 4

From: Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

Fig. 4

CART analyses of pCR in BC patients treated with TAC chemotherapy. The tree is divided by the SNPs to predict pCR, which has a significant prediction score (AUC 0.613 95 % CI 0.518–0.707, P = 0.040). IGFBP3 insulin-like growth factor binding protein 3, IGF1R insulin-like growth factor 1 receptor, pCR pathological complete response

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us